Pharma-Bio Serv (PBSV) Revenue (2010 - 2026)

Pharma-Bio Serv's Revenue history runs 16 years deep, the most recent figure standing at $2.7 million for Q2 2026.

• Quarterly Revenue rose 11.83% year-over-year to $2.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $9.1 million (down 5.49% YoY) and the FY2025 annual result came in at $9.0 million, down 5.34% from the prior year.
• Revenue was $2.7 million for Q2 2026 at Pharma-Bio Serv, up from $2.3 million in the prior quarter.
• Across five years, Revenue topped out at $5.0 million in Q1 2022 and bottomed at $2.0 million in Q3 2025.
• A 5-year average of $3.3 million and a median of $2.6 million in 2025 frame the typical range for Revenue.
• Annual changes were most pronounced in 2024 — Revenue sank 47.9% — and 2026, when it rose 11.83%.
• Pharma-Bio Serv's Revenue stood at $4.6 million in 2022, then declined by 22.42% to $3.6 million in 2023, then slumped by 35.15% to $2.3 million in 2024, then retreated by 7.87% to $2.1 million in 2025, then advanced by 25.74% to $2.7 million in 2026.
• Business Quant data shows PBSV's Revenue at $2.7 million in Q2 2026, $2.3 million in Q1 2026, and $2.1 million in Q4 2025.